Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation

References

• McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice: fourth national study 1991–1992. London: HMSO; 1995
   Google Scholar
• O’Keefe EA, Talley NJ, Zinsmeister AR, et al. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci 1995;50: M184–9
   Google Scholar
• Read NW, Celik AF, Katsinelos P. Constipation and incontinence in the elderly. J Clin Gastroenterol 1995;20:61–70
   PubMed Web of Science ®Google Scholar
• Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004;2 (Suppl 2): S3–10
   Google Scholar
• Müller-Lissner MD, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005;100:232–42
   Google Scholar
• Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996;91: 19–25
   Google Scholar
• Department of Health. Statistical bulletin 2000/20 – Prescriptions dispensed in the community, statistics for 1989 to 1999: England: UK Department of Health;, 2000
   Google Scholar
• Department of Health. Prescription cost analysis: England 2000 [cited 2001 10/8]. Available from: http:/www.doh.gov. uk/stats/pca2000.htm
   Google Scholar
• Kamm MA. Constipation and its management. BMJ 2003;327:459–60
   PubMed Web of Science ®Google Scholar
• Locke GR, Pemberton JH, Phillips SF. AGA technical review on constipation. American Gastroenterology Association. Gastroenterology 2000;119:1766–78
   PubMedGoogle Scholar
• Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45 (Suppl II):II43–7
   Google Scholar
• Veldhuyzen van Zanten SJO, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45 (Suppl II):II69–77
   Google Scholar
• Hannay DR. Symptom prevalence in the community. JR Coll Gen Pract 1978;28:492–9
   Google Scholar
• Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home. Definition, prevalence and relationship to lifestyle and health status. J Am Geriatr Soc 1989;37:423–9
   Google Scholar
• Wolfsen CR, Barker JC, Mitteness LS. Constipation in the daily lives of frail elderly people. Arch Fam Med 1993;2:853–8
   Google Scholar
• Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980;79: 283–8
   PubMed Web of Science ®Google Scholar
• Effective Health Care: Effectiveness of laxatives in adults. NHS Centre for Reviews and Dissemination 2001;7:1–12
   Google Scholar
• Petticrew M, Rodgers M, Booth A. Effectiveness of laxatives in adults. Qual Health Care 2001;10:268–73
   PubMed Web of Science ®Google Scholar
• Petticrew M, Watt I, Brand M. What’s the ‘best buy’ for treatment of constipation? Results of a systematic review of the efficacy and comparative efficacy of laxatives in the elderly. Br J Gen Pract 1999;49:387–93
   Google Scholar
• Jones MP, Talley NJ, Nuyts G, et al. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 2002;47:2222–30
   PubMed Web of Science ®Google Scholar
• Ramkumar D, Rao SC. Efficacy and safety of traditional medical therapies for chronic constipation: Systematic review. Am J Gastroenterol 2005;100:936–71
   PubMed Web of Science ®Google Scholar
• Kienzle-Horn S, Vix J-M, Schuijt C, et al. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study. Aliment Pharmacol Ther 2006, 23:1479–88
   Google Scholar
• Wulkow R, Vix J-M, Schuijt C, et al. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulfate in patients with chronic constipation. Gut 2006;55(Suppl):A254. United European Gastroenterology Week, 2006, Berlin
   Google Scholar
• Bergan T, Fotland MH, Sund RB. Interaction between diphenolic laxatives and intestinal bacteria in vitro. Acta Pharmacol Toxicol 1982;51:165–72
   Google Scholar
• Jauch R, Hankwitz R, Beschke R, et al. Bis-(p-hydroxyphenyl)-pyridyl-2-methane: the common laxative principle of bisacodyl and sodium picosulfate. Arzneim Forsch Drug Res 1975;25:1796–1800
   PubMed Web of Science ®Google Scholar
• Voderholzer WA, Morena MA, Schindlbeck NE. The influence of bisacodyl on human colon motility in vitro. Gastroenterology 2000;118\(Suppl 2, Part 1):A838; Digestive Disease Week and the 101st Ann Mtg of the Gastroenterological Association, San Diego, 21–24 May 2000
   Google Scholar
• Ewe K. Effect of bisacodyl on intestinal electrolyte and water net transport and transit. Digestion 1987;37:247–53
   PubMed Web of Science ®Google Scholar
• Rider JA. Treatment of acute and chronic constipation with bisoxatin acetate and bisacodyl. Double-blind crossover study. Curr Ther Res Clin Exp 1971;13:386–92
   PubMed Web of Science ®Google Scholar
• Janisch HD, Loose K, Schoenfeld H. Influence of cisapride (CIS) and bisacodyl (BIS) on hospital acquired constipation (HAC). Gastroenterology 1992;102:A15
   Google Scholar
• Ewe K, Ueberschaer B, Press AG, et al. Effect of lactose, lactulose and bisacodyl on gastrointestinal transit studies by metal detector. Aliment Pharmacol Ther 1995;9:69–73
   PubMed Web of Science ®Google Scholar
• Jones RF, Hall GJ. Management of the neurogenic bowel using durolax solution. Med J Australia 1979;1:309
   PubMed Web of Science ®Google Scholar
• Kim DH, Hyun SH, Shim SB, et al. The role of intestinal bacteria in the transformation of sodium picosulfate. Jpn J Pharmacol 1992;59:1–5
   PubMedGoogle Scholar
• Hamilton D, Mulcahy D, Walsh D, et al. Sodium picosulfate compared with polyethylene glycol solution for large bowel lavage: a prospective randomised trial. Br J Clin Pract 1996;50:73–5
   PubMedGoogle Scholar
• Regev A, Fraser G, Delpre G, et al. Comparison of two bowel preparations for colonoscopy: sodium picosulfate with magnesium citrate versus sulphate-free polyethylene glycol lavage solution. Am J Gastroenterol 1998;93:1478–82
   PubMed Web of Science ®Google Scholar
• Taylor SA, Halligan S, Goh V, et al. Optimizing bowel preparation for multidetector row CT colonography: effect of Citramag and Picolax. Clin Radiol 2003;58:723–32
   PubMed Web of Science ®Google Scholar
• Emmanuel AV, Roy AJ, Nicholls TJ, et al. Prucalopride, a systemic enterokinetic for the treatment of constipation. Aliment Pharmacol Ther 2002;16:1347–56
   PubMed Web of Science ®Google Scholar
• Connolly P, Hughes IW, Ryan G. Comparison of ‘Duphalac’ and ‘irritant’ laxatives during and after treatment of chronic constipation: a preliminary study. Curr Med Res Opin 1975;2:620–5
   Google Scholar
• Mueller-Lissner S, Kamm MA, Musoglu A, et al. Safety, tolerability, and effect of tegaserod over 13 months in patients with chronic constipation. Am J Gastroenterol 2006;101: 2558–69
   Google Scholar
• Kamm MA, Mueller-Lissner S, Talley NJ, et al. Tegaserod fort he treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005;100:362–72
   PubMed Web of Science ®Google Scholar
• Fried M, Johanson JF, Gwee KA, et al. efficacy of tegaserod in chronic constipation in men. Am J Gastroenterol 2007;102: 362–70
   PubMed Web of Science ®Google Scholar
• Maclennan WJ, Pooler AFWM. A comparison of sodium pico-sulphate (‘Laxoberal’) with standardised senna (‘Senokot’) in geriatric patients. Curr Med Res Opin 1975;2:641–7
   Google Scholar
• Bengtsson M, Ohlsson B. Retrospective study of long-term treatment with sodium picosulfate. Eur J Gastroenterol Hepatol 2004;16:433–4
   PubMed Web of Science ®Google Scholar